-
1
-
-
0030671044
-
Coexpression of CD69 and HLADR activation markers on synovial fluid T lymphocytes of patients affected by rheumatoid arthritis: A three-colour cytometric analysis
-
Afeltra A, Galeazzi M, Sebastiani GD, Ferri GM, Caccavo D, Addessi MA, Marcolongo R, Bonomo L (1997) Coexpression of CD69 and HLADR activation markers on synovial fluid T lymphocytes of patients affected by rheumatoid arthritis: a three-colour cytometric analysis. Int J Exp Pathol 78(5): 331-336
-
(1997)
Int J Exp Pathol
, vol.78
, Issue.5
, pp. 331-336
-
-
Afeltra, A.1
Galeazzi, M.2
Sebastiani, G.D.3
Ferri, G.M.4
Caccavo, D.5
Addessi, M.A.6
Marcolongo, R.7
Bonomo, L.8
-
2
-
-
40949119354
-
Impact of tumor-infiltrating T cells on survival in patients with malignant pleural mesothelioma
-
Anraku M, Cunningham KS, Yun Z, Tsao MS, Tsao MS, Zhang L, Keshavjee S, Johnston MR, de Perrot M (2008) Impact of tumor-infiltrating T cells on survival in patients with malignant pleural mesothelioma. J Thorac Cardiovasc Surg 135(4): 823-829
-
(2008)
J Thorac Cardiovasc Surg
, vol.135
, Issue.4
, pp. 823-829
-
-
Anraku, M.1
Cunningham, K.S.2
Yun, Z.3
Tsao, M.S.4
Tsao, M.S.5
Zhang, L.6
Keshavjee, S.7
Johnston, M.R.8
De Perrot, M.9
-
3
-
-
77955483885
-
Synergistic antitumor effects of regulatory T cell blockade combined with pemetrexed in murine malignant mesothelioma
-
Anraku M, Tagawa T, Wu L, Yun Z, Keshavjee S, Zhang L, Johnston MR, de Perrot M (2010) Synergistic antitumor effects of regulatory T cell blockade combined with pemetrexed in murine malignant mesothelioma. J Immunol 185(2): 956-966
-
(2010)
J Immunol
, vol.185
, Issue.2
, pp. 956-966
-
-
Anraku, M.1
Tagawa, T.2
Wu, L.3
Yun, Z.4
Keshavjee, S.5
Zhang, L.6
Johnston, M.R.7
De Perrot, M.8
-
4
-
-
0019475622
-
Mathematic coupling of data: A common source of error
-
Archie Jr JP (1981) Mathematic coupling of data: a common source of error. Ann Surg 193(3): 296-303
-
(1981)
Ann Surg
, vol.193
, Issue.3
, pp. 296-303
-
-
Archie Jr., J.P.1
-
5
-
-
67649422143
-
Impact of surgery and chemotherapy on cellular immunity in pancreatic carcinoma patients in view of an integration of standard cancer treatment with immunotherapy
-
Bellone G, Novarino A, Vizio B, Brondino G, Addeo A, Prati A, Giacobino A, Campra D, Fronda GR, Ciuffreda L (2009) Impact of surgery and chemotherapy on cellular immunity in pancreatic carcinoma patients in view of an integration of standard cancer treatment with immunotherapy. Int J Oncol 34(6): 1701-1715
-
(2009)
Int J Oncol
, vol.34
, Issue.6
, pp. 1701-1715
-
-
Bellone, G.1
Novarino, A.2
Vizio, B.3
Brondino, G.4
Addeo, A.5
Prati, A.6
Giacobino, A.7
Campra, D.8
Fronda, G.R.9
Ciuffreda, L.10
-
6
-
-
0031744154
-
B cells directly tolerize CD8( +) T cells
-
Bennett SR, Carbone FR, Toy T, Miller JF, Heath WR (1998) B cells directly tolerize CD8( +) T cells. J Exp Med 188(11): 1977-1983
-
(1998)
J Exp Med
, vol.188
, Issue.11
, pp. 1977-1983
-
-
Bennett, S.R.1
Carbone, F.R.2
Toy, T.3
Miller, J.F.4
Heath, W.R.5
-
7
-
-
1342267614
-
Modified RECIST criteria for assessment of response in malignant pleural mesothelioma
-
Byrne MJ, Nowak AK (2004) Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. Ann Oncol 15(2): 257-260
-
(2004)
Ann Oncol
, vol.15
, Issue.2
, pp. 257-260
-
-
Byrne, M.J.1
Nowak, A.K.2
-
8
-
-
0032482177
-
Direct visualization of antigenspecific CD8 + T cells during the primary immune response to Epstein-Barr virus in vivo
-
Callan MF, Tan L, Annels N, Ogg GS, Wilson JD, O'Callaghan CA, Steven N, McMichael AJ, Rickinson AB (1998) Direct visualization of antigenspecific CD8 + T cells during the primary immune response to Epstein-Barr virus In vivo. J Exp Med 187(9): 1395-1402
-
(1998)
J Exp Med
, vol.187
, Issue.9
, pp. 1395-1402
-
-
Callan, M.F.1
Tan, L.2
Annels, N.3
Ogg, G.S.4
Wilson, J.D.5
O'Callaghan, C.A.6
Steven, N.7
McMichael, A.J.8
Rickinson, A.B.9
-
9
-
-
29144530630
-
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
-
Casares N, Pequignot MO, Tesniere A, Ghiringhelli F, Roux S, Chaput N, Schmitt E, Hamai A, Hervas-Stubbs S, Obeid M, Coutant F, Metivier D, Pichard E, Aucouturier P, Pierron G, Garrido C, Zitvogel L, Kroemer G (2005) Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. J Exp Med 202(12): 1691-1701
-
(2005)
J Exp Med
, vol.202
, Issue.12
, pp. 1691-1701
-
-
Casares, N.1
Pequignot, M.O.2
Tesniere, A.3
Ghiringhelli, F.4
Roux, S.5
Chaput, N.6
Schmitt, E.7
Hamai, A.8
Hervas-Stubbs, S.9
Obeid, M.10
Coutant, F.11
Metivier, D.12
Pichard, E.13
Aucouturier, P.14
Pierron, G.15
Garrido, C.16
Zitvogel, L.17
Kroemer, G.18
-
10
-
-
0034796870
-
Development of tumor-infiltrating lymphocytes in breast cancer after neoadjuvant paclitaxel chemotherapy
-
Demaria S, Volm MD, Shapiro RL, Yee HT, Oratz R, Formenti SC, Muggia F, Symmans WF (2001) Development of tumor-infiltrating lymphocytes in breast cancer after neoadjuvant paclitaxel chemotherapy. Clin Cancer Res 7(10): 3025-3030
-
(2001)
Clin Cancer Res
, vol.7
, Issue.10
, pp. 3025-3030
-
-
Demaria, S.1
Volm, M.D.2
Shapiro, R.L.3
Yee, H.T.4
Oratz, R.5
Formenti, S.C.6
Muggia, F.7
Symmans, W.F.8
-
11
-
-
0033849171
-
Prognostic factors for malignant mesothelioma in 142 patients: Validation of CALGB and EORTC prognostic scoring systems
-
Edwards JG, Abrams KR, Leverment JN, Spyt TJ, Waller DA, O'Byrne KJ (2000) Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems. Thorax 55(9): 731-735
-
(2000)
Thorax
, vol.55
, Issue.9
, pp. 731-735
-
-
Edwards, J.G.1
Abrams, K.R.2
Leverment, J.N.3
Spyt, T.J.4
Waller, D.A.5
O'Byrne, K.J.6
-
12
-
-
0041884743
-
Continuous activation of autoreactive CD4 + CD25 + regulatory T cells in the steady state
-
Fisson S, Darrasse-Jeze G, Litvinova E, Septier F, Klatzmann D, Liblau R, Salomon BL (2003) Continuous activation of autoreactive CD4 + CD25 + regulatory T cells in the steady state. J Exp Med 198(5): 737-746
-
(2003)
J Exp Med
, vol.198
, Issue.5
, pp. 737-746
-
-
Fisson, S.1
Darrasse-Jeze, G.2
Litvinova, E.3
Septier, F.4
Klatzmann, D.5
Liblau, R.6
Salomon, B.L.7
-
13
-
-
68749098345
-
A prognostic index for progression-free survival in malignant mesothelioma with application to the design of phase II trials: A combined analysis of 10 EORTC trials
-
Francart J, Vaes E, Henrard S, Legrand C, Baas P, Gaafar R, van Meerbeeck JP, Sylvester R, Robert A (2009) A prognostic index for progression-free survival in malignant mesothelioma with application to the design of phase II trials: a combined analysis of 10 EORTC trials. Eur J Cancer 45(13): 2304-2311
-
(2009)
Eur J Cancer
, vol.45
, Issue.13
, pp. 2304-2311
-
-
Francart, J.1
Vaes, E.2
Henrard, S.3
Legrand, C.4
Baas, P.5
Gaafar, R.6
Van Meerbeeck, J.P.7
Sylvester, R.8
Robert, A.9
-
14
-
-
78049479930
-
Chemotherapy delivered after viral immunogene therapy augments antitumor efficacy via multiple immune-mediated mechanisms
-
Fridlender ZG, Sun J, Singhal S, Kapoor V, Cheng G, Suzuki E, Albelda SM (2010) Chemotherapy delivered after viral immunogene therapy augments antitumor efficacy via multiple immune-mediated mechanisms. Mol Ther 18(11): 1947-1959
-
(2010)
Mol Ther
, vol.18
, Issue.11
, pp. 1947-1959
-
-
Fridlender, Z.G.1
Sun, J.2
Singhal, S.3
Kapoor, V.4
Cheng, G.5
Suzuki, E.6
Albelda, S.M.7
-
15
-
-
0021212003
-
Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67
-
Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133(4): 1710-1715
-
(1984)
J Immunol
, vol.133
, Issue.4
, pp. 1710-1715
-
-
Gerdes, J.1
Lemke, H.2
Baisch, H.3
Wacker, H.H.4
Schwab, U.5
Stein, H.6
-
16
-
-
1642378018
-
CD4 +CD25 + regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative
-
Ghiringhelli F, Larmonier N, Schmitt E, Parcellier A, Cathelin D, Garrido C, Chauffert B, Solary E, Bonnotte B, Martin F (2004) CD4 +CD25 + regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative. Eur J Immunol 34(2): 336-344
-
(2004)
Eur J Immunol
, vol.34
, Issue.2
, pp. 336-344
-
-
Ghiringhelli, F.1
Larmonier, N.2
Schmitt, E.3
Parcellier, A.4
Cathelin, D.5
Garrido, C.6
Chauffert, B.7
Solary, E.8
Bonnotte, B.9
Martin, F.10
-
17
-
-
33847368549
-
Metronomic cyclophosphamide regimen selectively depletes CD4 +CD25 + regulatory T cells and restores T and NK effector functions in end stage cancer patients
-
Ghiringhelli F, Menard C, Puig PE, Ladoire S, Roux S, Martin F, Solary E, Le Cesne A, Zitvogel L, Chauffert B (2007) Metronomic cyclophosphamide regimen selectively depletes CD4 +CD25 + regulatory T cells and restores T and NK effector functions in end stage cancer patients. Cancer Immunol Immunother 56(5): 641-648
-
(2007)
Cancer Immunol Immunother
, vol.56
, Issue.5
, pp. 641-648
-
-
Ghiringhelli, F.1
Menard, C.2
Puig, P.E.3
Ladoire, S.4
Roux, S.5
Martin, F.6
Solary, E.7
Le Cesne, A.8
Zitvogel, L.9
Chauffert, B.10
-
18
-
-
0034655122
-
Cutting edge: Increased expression of Bcl-2 in antigen-specific memory CD8 + T cells
-
Grayson JM, Zajac AJ, Altman JD, Ahmed R (2000) Cutting edge: increased expression of Bcl-2 in antigen-specific memory CD8 + T cells. J Immunol 164(8): 3950-3954
-
(2000)
J Immunol
, vol.164
, Issue.8
, pp. 3950-3954
-
-
Grayson, J.M.1
Zajac, A.J.2
Altman, J.D.3
Ahmed, R.4
-
19
-
-
0031887839
-
Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B
-
Herndon JE, Green MR, Chahinian AP, Corson JM, Suzuki Y, Vogelzang NJ (1998) Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B. Chest 113(3): 723-731
-
(1998)
Chest
, vol.113
, Issue.3
, pp. 723-731
-
-
Herndon, J.E.1
Green, M.R.2
Chahinian, A.P.3
Corson, J.M.4
Suzuki, Y.5
Vogelzang, N.J.6
-
20
-
-
42249115188
-
Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating foxp3 + regulatory T cells
-
Ladoire S, Arnould L, Apetoh L, Coudert B, Martin F, Chauffert B, Fumoleau P, Ghiringhelli F (2008) Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating foxp3 + regulatory T cells. Clin Cancer Res 14(8): 2413-2420
-
(2008)
Clin Cancer Res
, vol.14
, Issue.8
, pp. 2413-2420
-
-
Ladoire, S.1
Arnould, L.2
Apetoh, L.3
Coudert, B.4
Martin, F.5
Chauffert, B.6
Fumoleau, P.7
Ghiringhelli, F.8
-
21
-
-
18344375283
-
Immunotherapy and chemotherapy - A practical partnership
-
Lake RA, Robinson BW (2005) Immunotherapy and chemotherapy-a practical partnership. Nat Rev Cancer 5(5): 397-405
-
(2005)
Nat Rev Cancer
, vol.5
, Issue.5
, pp. 397-405
-
-
Lake, R.A.1
Robinson, B.W.2
-
22
-
-
33745817085
-
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4 + T reg cells
-
Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, Zhu S, Gottlieb PA, Kapranov P, Gingeras TR, Fazekas de St Groth B, Clayberger C, Soper DM, Ziegler SF, Bluestone JA (2006) CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4 + T reg cells. J Exp Med 203(7): 1701-1711
-
(2006)
J Exp Med
, vol.203
, Issue.7
, pp. 1701-1711
-
-
Liu, W.1
Putnam, A.L.2
Xu-Yu, Z.3
Szot, G.L.4
Lee, M.R.5
Zhu, S.6
Gottlieb, P.A.7
Kapranov, P.8
Gingeras, T.R.9
Fazekas De St Groth, B.10
Clayberger, C.11
Soper, D.M.12
Ziegler, S.F.13
Bluestone, J.A.14
-
23
-
-
0035328683
-
Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice
-
Machiels JP, Reilly RT, Emens LA, Ercolini AM, Lei RY, Weintraub D, Okoye FI, Jaffee EM (2001) Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice. Cancer Res 61(9): 3689-3697
-
(2001)
Cancer Res
, vol.61
, Issue.9
, pp. 3689-3697
-
-
MacHiels, J.P.1
Reilly, R.T.2
Emens, L.A.3
Ercolini, A.M.4
Lei, R.Y.5
Weintraub, D.6
Okoye, F.I.7
Jaffee, E.M.8
-
24
-
-
18744435046
-
Restoration of T-cell homeostasis after T-cell depletion
-
Mackall CL, Hakim FT, Gress RE (1997) Restoration of T-cell homeostasis after T-cell depletion. Semin Immunol 9(6): 339-346
-
(1997)
Semin Immunol
, vol.9
, Issue.6
, pp. 339-346
-
-
MacKall, C.L.1
Hakim, F.T.2
Gress, R.E.3
-
25
-
-
33747164218
-
A prognostic model for advanced stage nonsmall cell lung cancer Pooled analysis of North Central Cancer Treatment Group trials
-
Mandrekar SJ, Schild SE, Hillman SL, Allen KL, Marks RS, Mailliard JA, Krook JE, Maksymiuk AW, Chansky K, Kelly K, Adjei AA, Jett JR (2006) A prognostic model for advanced stage nonsmall cell lung cancer. Pooled analysis of North Central Cancer Treatment Group trials. Cancer 107(4): 781-792
-
(2006)
Cancer
, vol.107
, Issue.4
, pp. 781-792
-
-
Mandrekar, S.J.1
Schild, S.E.2
Hillman, S.L.3
Allen, K.L.4
Marks, R.S.5
Mailliard, J.A.6
Krook, J.E.7
Maksymiuk, A.W.8
Chansky, K.9
Kelly, K.10
Adjei, A.A.11
Jett, J.R.12
-
26
-
-
43049154506
-
Human effector and memory CD8 + T cell responses to smallpox and yellow fever vaccines
-
Miller JD, van der Most RG, Akondy RS, Glidewell JT, Albott S, Masopust D, Murali-Krishna K, Mahar PL, Edupuganti S, Lalor S, Germon S, Del Rio C, Mulligan MJ, Staprans SI, Altman JD, Feinberg MB, Ahmed R (2008) Human effector and memory CD8 + T cell responses to smallpox and yellow fever vaccines. Immunity 28(5): 710-722
-
(2008)
Immunity
, vol.28
, Issue.5
, pp. 710-722
-
-
Miller, J.D.1
Van Der Most, R.G.2
Akondy, R.S.3
Glidewell, J.T.4
Albott, S.5
Masopust, D.6
Murali-Krishna, K.7
Mahar, P.L.8
Edupuganti, S.9
Lalor, S.10
Germon, S.11
Del Rio, C.12
Mulligan, M.J.13
Staprans, S.I.14
Altman, J.D.15
Feinberg, M.B.16
Ahmed, R.17
-
27
-
-
43449092540
-
Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): A multicentre randomised trial
-
Muers MF, Stephens RJ, Fisher P, Darlison L, Higgs CM, Lowry E, Nicholson AG, O'Brien M, Peake M, Rudd R, Snee M, Steele J, Girling DJ, Nankivell M, Pugh C, Parmar MK (2008) Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial. Lancet 371(9625): 1685-1694
-
(2008)
Lancet
, vol.371
, Issue.9625
, pp. 1685-1694
-
-
Muers, M.F.1
Stephens, R.J.2
Fisher, P.3
Darlison, L.4
Higgs, C.M.5
Lowry, E.6
Nicholson, A.G.7
O'Brien, M.8
Peake, M.9
Rudd, R.10
Snee, M.11
Steele, J.12
Girling, D.J.13
Nankivell, M.14
Pugh, C.15
Parmar, M.K.16
-
28
-
-
58149376993
-
Chemotherapy enhances vaccine-induced antitumor immunity in melanoma patients
-
Nistico P, Capone I, Palermo B, Del Bello D, Ferraresi V, Moschella F, Arico E, Valentini M, Bracci L, Cognetti F, Ciccarese M, Vercillo G, Roselli M, Fossile E, Tosti ME, Wang E, Marincola F, Imberti L, Catricala C, Natali PG, Belardelli F, Proietti E (2009) Chemotherapy enhances vaccine-induced antitumor immunity in melanoma patients. Int J Cancer 124(1): 130-139
-
(2009)
Int J Cancer
, vol.124
, Issue.1
, pp. 130-139
-
-
Nistico, P.1
Capone, I.2
Palermo, B.3
Del Bello, D.4
Ferraresi, V.5
Moschella, F.6
Arico, E.7
Valentini, M.8
Bracci, L.9
Cognetti, F.10
Ciccarese, M.11
Vercillo, G.12
Roselli, M.13
Fossile, E.14
Tosti, M.E.15
Wang, E.16
Marincola, F.17
Imberti, L.18
Catricala, C.19
Natali, P.G.20
Belardelli, F.21
Proietti, E.22
more..
-
29
-
-
77951017506
-
A novel prognostic model for malignant mesothelioma incorporating quantitative FDG-PET imaging with clinical parameters
-
Nowak AK, Francis RJ, Phillips MJ, Millward MJ, van der Schaaf AA, Boucek J, Musk AW, McCoy MJ, Segal A, Robins P, Byrne MJ (2010) A novel prognostic model for malignant mesothelioma incorporating quantitative FDG-PET imaging with clinical parameters. Clin Cancer Res 16(8): 2409-2417
-
(2010)
Clin Cancer Res
, vol.16
, Issue.8
, pp. 2409-2417
-
-
Nowak, A.K.1
Francis, R.J.2
Phillips, M.J.3
Millward, M.J.4
Van Der Schaaf, A.A.5
Boucek, J.6
Musk, A.W.7
McCoy, M.J.8
Segal, A.9
Robins, P.10
Byrne, M.J.11
-
30
-
-
0038326676
-
Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells
-
Nowak AK, Lake RA, Marzo AL, Scott B, Heath WR, Collins EJ, Frelinger JA, Robinson BW (2003) Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells. J Immunol 170(10): 4905-4913
-
(2003)
J Immunol
, vol.170
, Issue.10
, pp. 4905-4913
-
-
Nowak, A.K.1
Lake, R.A.2
Marzo, A.L.3
Scott, B.4
Heath, W.R.5
Collins, E.J.6
Frelinger, J.A.7
Robinson, B.W.8
-
32
-
-
0037089545
-
Gemcitabine exerts a selective effect on the humoral immune response: Implications for combination chemo-immunotherapy
-
Nowak AK, Robinson BW, Lake RA (2002) Gemcitabine exerts a selective effect on the humoral immune response: implications for combination chemo-immunotherapy. Cancer Res 62(8): 2353-2358
-
(2002)
Cancer Res
, vol.62
, Issue.8
, pp. 2353-2358
-
-
Nowak, A.K.1
Robinson, B.W.2
Lake, R.A.3
-
33
-
-
0042591416
-
Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors
-
Nowak AK, Robinson BW, Lake RA (2003) Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors. Cancer Res 63(15): 4490-4496
-
(2003)
Cancer Res
, vol.63
, Issue.15
, pp. 4490-4496
-
-
Nowak, A.K.1
Robinson, B.W.2
Lake, R.A.3
-
34
-
-
77956920709
-
Dacarbazine treatment before peptide vaccination enlarges T-cell repertoire diversity of melan-a-specific, tumor-reactive CTL in melanoma patients
-
Palermo B, Del Bello D, Sottini A, Serana F, Ghidini C, Gualtieri N, Ferraresi V, Catricala C, Belardelli F, Proietti E, Natali PG, Imberti L, Nistico P (2010) Dacarbazine treatment before peptide vaccination enlarges T-cell repertoire diversity of melan-a-specific, tumor-reactive CTL in melanoma patients. Cancer Res 70(18): 7084-7092
-
(2010)
Cancer Res
, vol.70
, Issue.18
, pp. 7084-7092
-
-
Palermo, B.1
Del Bello, D.2
Sottini, A.3
Serana, F.4
Ghidini, C.5
Gualtieri, N.6
Ferraresi, V.7
Catricala, C.8
Belardelli, F.9
Proietti, E.10
Natali, P.G.11
Imberti, L.12
Nistico, P.13
-
35
-
-
0038696434
-
T cell activation and enhanced apoptosis in non-ST elevation myocardial infarction
-
Pasqui AL, Di Renzo M, Bova G, Bruni F, Puccetti L, Pompella G, Auteri A (2003) T cell activation and enhanced apoptosis in non-ST elevation myocardial infarction. Clin Exp Med 3(1): 37-44
-
(2003)
Clin Exp Med
, vol.3
, Issue.1
, pp. 37-44
-
-
Pasqui, A.L.1
Di Renzo, M.2
Bova, G.3
Bruni, F.4
Puccetti, L.5
Pompella, G.6
Auteri, A.7
-
36
-
-
22244489353
-
Effect of gemcitabine on immune cells in subjects with adenocarcinoma of the pancreas
-
Plate JMD, Plate AAE, Shott S, Bograd S, Harris JE (2005) Effect of gemcitabine on immune cells in subjects with adenocarcinoma of the pancreas. Cancer Immunol Immunother 54(9): 915-925
-
(2005)
Cancer Immunol Immunother
, vol.54
, Issue.9
, pp. 915-925
-
-
Jmd, P.1
Aae, P.2
Shott, S.3
Bograd, S.4
Harris, J.E.5
-
37
-
-
0031863680
-
B cells inhibit induction of T cell-dependent tumor immunity
-
Qin Z, Richter G, Schuler T, Ibe S, Cao X, Blankenstein T (1998) B cells inhibit induction of T cell-dependent tumor immunity. Nat Med 4(5): 627-630
-
(1998)
Nat Med
, vol.4
, Issue.5
, pp. 627-630
-
-
Qin, Z.1
Richter, G.2
Schuler, T.3
Ibe, S.4
Cao, X.5
Blankenstein, T.6
-
38
-
-
79959733137
-
Gemcitabine depletes regulatory T-cells in human and mice and enhances triggering of vaccine-specific cytotoxic T-cells
-
Rettig L, Seidenberg S, Parvanova I, Samaras P, Knuth A, Pascolo S (2011) Gemcitabine depletes regulatory T-cells in human and mice and enhances triggering of vaccine-specific cytotoxic T-cells. Int J Cancer 129(4): 832-838
-
(2011)
Int J Cancer
, vol.129
, Issue.4
, pp. 832-838
-
-
Rettig, L.1
Seidenberg, S.2
Parvanova, I.3
Samaras, P.4
Knuth, A.5
Pascolo, S.6
-
39
-
-
77954141914
-
FOXP3 + regulatory T cells in the human immune system
-
Sakaguchi S, Miyara M, Costantino CM, Hafler DA (2010) FOXP3 + regulatory T cells in the human immune system. Nat Rev Immunol 10(7): 490-500
-
(2010)
Nat Rev Immunol
, vol.10
, Issue.7
, pp. 490-500
-
-
Sakaguchi, S.1
Miyara, M.2
Costantino, C.M.3
Hafler, D.A.4
-
40
-
-
49049089802
-
Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer
-
Scagliotti GV, Parikh P, von Pawel J, Biesma B, Vansteenkiste J, Manegold C, Serwatowski P, Gatzemeier U, Digumarti R, Zukin M, Lee JS, Mellemgaard A, Park K, Patil S, Rolski J, Goksel T, de Marinis F, Simms L, Sugarman KP, Gandara D (2008) Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 26(21): 3543-3551
-
(2008)
J Clin Oncol
, vol.26
, Issue.21
, pp. 3543-3551
-
-
Scagliotti, G.V.1
Parikh, P.2
Von Pawel, J.3
Biesma, B.4
Vansteenkiste, J.5
Manegold, C.6
Serwatowski, P.7
Gatzemeier, U.8
Digumarti, R.9
Zukin, M.10
Lee, J.S.11
Mellemgaard, A.12
Park, K.13
Patil, S.14
Rolski, J.15
Goksel, T.16
De Marinis, F.17
Simms, L.18
Sugarman, K.P.19
Gandara, D.20
more..
-
41
-
-
0037050352
-
Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer
-
Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J, Zhu J, Johnson DH (2002) Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 346(2): 92-98
-
(2002)
N Engl J Med
, vol.346
, Issue.2
, pp. 92-98
-
-
Schiller, J.H.1
Harrington, D.2
Belani, C.P.3
Langer, C.4
Sandler, A.5
Krook, J.6
Zhu, J.7
Johnson, D.H.8
-
42
-
-
0034332403
-
Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo
-
Schluns KS, Kieper WC, Jameson SC, Lefrancois L (2000) Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat Immunol 1(5): 426-432
-
(2000)
Nat Immunol
, vol.1
, Issue.5
, pp. 426-432
-
-
Schluns, K.S.1
Kieper, W.C.2
Jameson, S.C.3
Lefrancois, L.4
-
43
-
-
33645510596
-
Persistence of naive CD45RA + regulatory T cells in adult life
-
Seddiki N, Santner-Nanan B, Tangye SG, Alexander SI, Solomon M, Lee S, Nanan R, Fazekas de Saint Groth B (2006) Persistence of naive CD45RA + regulatory T cells in adult life. Blood 107(7): 2830-2838
-
(2006)
Blood
, vol.107
, Issue.7
, pp. 2830-2838
-
-
Seddiki, N.1
Santner-Nanan, B.2
Tangye, S.G.3
Alexander, S.I.4
Solomon, M.5
Lee, S.6
Nanan, R.7
Fazekas De Saint Groth, B.8
-
44
-
-
85027957593
-
Immunomodulatory effects of cyclophosphamide and implementations for vaccine design
-
Sistigu A, Viaud S, Chaput N, Bracci L, Proietti E, Zitvogel L (2011) Immunomodulatory effects of cyclophosphamide and implementations for vaccine design. Semin Immunopathol 33(4): 369-383
-
(2011)
Semin Immunopathol
, vol.33
, Issue.4
, pp. 369-383
-
-
Sistigu, A.1
Viaud, S.2
Chaput, N.3
Bracci, L.4
Proietti, E.5
Zitvogel, L.6
-
45
-
-
0037124366
-
Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8 + cells but are not required for memory phenotype CD4 + cells
-
Tan JT, Ernst B, Kieper WC, LeRoy E, Sprent J, Surh CD (2002) Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8 + cells but are not required for memory phenotype CD4 + cells. J Exp Med 195(12): 1523-1532
-
(2002)
J Exp Med
, vol.195
, Issue.12
, pp. 1523-1532
-
-
Tan, J.T.1
Ernst, B.2
Kieper, W.C.3
Leroy, E.4
Sprent, J.5
Surh, C.D.6
-
46
-
-
0034594628
-
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada
-
Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92(3): 205-216
-
(2000)
J Natl Cancer Inst
, vol.92
, Issue.3
, pp. 205-216
-
-
Therasse, P.1
Arbuck, S.G.2
Eisenhauer, E.A.3
Wanders, J.4
Kaplan, R.S.5
Rubinstein, L.6
Verweij, J.7
Van Glabbeke, M.8
Van Oosterom, A.T.9
Christian, M.C.10
Gwyther, S.G.11
-
47
-
-
47649119341
-
Pretreatment with cisplatin enhances E7-specific CD8 + T-cell-mediated antitumor immunity induced by DNA vaccination
-
Tseng CW, Hung CF, Alvarez RD, Trimble C, Huh WK, Kim D, Chuang CM, Lin CT, Tsai YC, He L, Monie A, Wu TC (2008) Pretreatment with cisplatin enhances E7-specific CD8 + T-cell-mediated antitumor immunity induced by DNA vaccination. Clin Cancer Res 14(10): 3185-3192
-
(2008)
Clin Cancer Res
, vol.14
, Issue.10
, pp. 3185-3192
-
-
Tseng, C.W.1
Hung, C.F.2
Alvarez, R.D.3
Trimble, C.4
Huh, W.K.5
Kim, D.6
Chuang, C.M.7
Lin, C.T.8
Tsai, Y.C.9
He, L.10
Monie, A.11
Wu, T.C.12
-
48
-
-
67349250111
-
Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: A role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapy
-
van der Most RG, Currie AJ, Mahendran S, Prosser A, Darabi A, Robinson BW, Nowak AK, Lake RA (2009) Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapy. Cancer Immunol Immunother 58(8): 1219-1228
-
(2009)
Cancer Immunol Immunother
, vol.58
, Issue.8
, pp. 1219-1228
-
-
Van Der Most, R.G.1
Currie, A.J.2
Mahendran, S.3
Prosser, A.4
Darabi, A.5
Robinson, B.W.6
Nowak, A.K.7
Lake, R.A.8
-
49
-
-
0041629528
-
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma
-
Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, Gatzemeier U, Boyer M, Emri S, Manegold C, Niyikiza C, Paoletti P (2003) Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21(14): 2636-2644
-
(2003)
J Clin Oncol
, vol.21
, Issue.14
, pp. 2636-2644
-
-
Vogelzang, N.J.1
Rusthoven, J.J.2
Symanowski, J.3
Denham, C.4
Kaukel, E.5
Ruffie, P.6
Gatzemeier, U.7
Boyer, M.8
Emri, S.9
Manegold, C.10
Niyikiza, C.11
Paoletti, P.12
-
50
-
-
33748296240
-
Human CD4 + CD25hi Foxp3 + regulatory T cells are derived by rapid turnover of memory populations in vivo
-
Vukmanovic-Stejic M, Zhang Y, Cook JE, Fletcher JM, McQuaid A, Masters JE, Rustin MH, Taams LS, Beverley PC, Macallan DC, Akbar AN (2006) Human CD4 + CD25hi Foxp3 + regulatory T cells are derived by rapid turnover of memory populations in vivo. J Clin Invest 116(9): 2423-2433
-
(2006)
J Clin Invest
, vol.116
, Issue.9
, pp. 2423-2433
-
-
Vukmanovic-Stejic, M.1
Zhang, Y.2
Cook, J.E.3
Fletcher, J.M.4
McQuaid, A.5
Masters, J.E.6
Rustin, M.H.7
Taams, L.S.8
Beverley, P.C.9
MacAllan, D.C.10
Akbar, A.N.11
-
51
-
-
38949216307
-
Changes in cellular immunity during chemotherapy for primary breast cancer with anthracycline regimens
-
Wijayahadi N, Haron MR, Stanslas J, Yusuf Z (2007) Changes in cellular immunity during chemotherapy for primary breast cancer with anthracycline regimens. J Chemother 19(6): 176-723
-
(2007)
J Chemother
, vol.19
, Issue.6
, pp. 176-723
-
-
Wijayahadi, N.1
Haron, M.R.2
Stanslas, J.3
Yusuf, Z.4
-
52
-
-
34848879000
-
Low-dose paclitaxel prior to intratumoral dendritic cell vaccine modulates intratumoral cytokine network and lung cancer growth
-
Zhong H, Han B, Tourkova IL, Lokshin A, Rosenbloom A, Shurin MR, Shurin GV (2007) Low-dose paclitaxel prior to intratumoral dendritic cell vaccine modulates intratumoral cytokine network and lung cancer growth. Clin Cancer Res 13(18): 5455-5462
-
(2007)
Clin Cancer Res
, vol.13
, Issue.18
, pp. 5455-5462
-
-
Zhong, H.1
Han, B.2
Tourkova, I.L.3
Lokshin, A.4
Rosenbloom, A.5
Shurin, M.R.6
Shurin, G.V.7
-
53
-
-
77953701142
-
Immunogenic tumor cell death for optimal anticancer therapy: The calreticulin exposure pathway
-
Zitvogel L, Kepp O, Senovilla L, Menger L, Chaput N, Kroemer G (2010) Immunogenic tumor cell death for optimal anticancer therapy: the calreticulin exposure pathway. Clin Cancer Res 16(12): 3100-3104
-
(2010)
Clin Cancer Res
, vol.16
, Issue.12
, pp. 3100-3104
-
-
Zitvogel, L.1
Kepp, O.2
Senovilla, L.3
Menger, L.4
Chaput, N.5
Kroemer, G.6
|